MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$1,985K
Net Income
-$10,117K
Net Profit Margin
-509.67%
EPS
-$0.57
Unit: Thousand (K) dollars
Revenue Breakdown
Consumables
Instruments
Service
Instrument rentals
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2024-09-30
Revenue from contract with customer, excluding assessed tax, total
1,985
Selling, general and administrative expense
5,378
Research and development expense
2,667
Cost of goods and services sold
4,101
Costs and expenses
12,146
Operating income (loss)
-10,161
Other, net
16
Change in fair value of derivative warrant liability
321
Change in fair value of derivative related to term loan with related party
77
Interest expense to related party
370
Total other income (expense)
44
Net loss
-10,117
Basic EPS
-0.57
Diluted EPS
-0.57
Basic Average Shares
17,892,606
Diluted Average Shares
17,892,606
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Change in fair value of
derivative warrant...
$321K
Change in fair value of
derivative related to term...
$77K
Other, net
$16K
Net loss
-$10,117K
Total other income
(expense)
$44K
Consumables
$1,407K
Instruments
$440K
Service
$129K
Instrument rentals
$9K
Interest expense to
related party
$370K
Operating income (loss)
-$10,161K
Revenue from contract
with customer,...
$1,985K
Costs and expenses
$12,146K
Selling, general and
administrative expense
$5,378K
Cost of goods and
services sold
$4,101K
Research and development
expense
$2,667K
Buy us a coffee
T2 Biosystems, Inc. (TTOO)
T2 Biosystems, Inc. (TTOO)